Who owns ISIS Pharmaceuticals?

Key details on ISIS Pharmaceuticals (Ticker: ISIS)

Who owns ISIS Pharmaceuticals?

Is ISIS a good stock to own? Find out who bought ISIS Pharmaceuticals, who sold ISIS Pharmaceuticals (ISIS) stock, and who holds a large position in ISIS Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 17.55M $758.32M March 31, 2014
Artisan Partners Limited Partnership 8.76M $378.60M March 31, 2014
Vanguard 7.79M $336.45M March 31, 2014
ClearBridge Advisors 7.34M $317.35M March 31, 2014
BB Biotech AG 6.30M $272.29M March 31, 2014
Waddell & Reed Financial 5.31M $229.66M March 31, 2014
Columbia Wanger Asset Management 5.08M $71.52M Sept. 30, 2012
BlackRock Fund Advisors 4.38M $189.39M March 31, 2014
T. Rowe Price Associates 3.23M $139.54M March 31, 2014
BlackRock Institutional Trust Company, N.A. 3.13M $135.31M March 31, 2014
STATE STREET CORPORATION 2.41M $104.09M March 31, 2014
Jennison Associates 2.20M $95.09M March 31, 2014
BVF 2.16M $25.94M June 30, 2012
Franklin Resources 2.11M $91.17M March 31, 2014
SUSQUEHANNA INTERNATIONAL 2.01M $86.92M March 31, 2014
Gail Mannix 1.94M $83.86M March 31, 2014
LORD, ABBETT & CO 1.78M $66.81M Sept. 30, 2013
Tocqueville Asset Management 1.66M $66.13M Dec. 31, 2013
BlackRock Advisors 1.53M $41.22M June 30, 2013
NORTHERN TRUST 1.52M $65.81M March 31, 2014
GOLDMAN SACHS 1.51M $65.28M March 31, 2014
ALLIANCEBERNSTEIN 1.47M $55.28M Sept. 30, 2013
Columbus Circle Investors 1.45M $62.63M March 31, 2014

Who sold ISIS Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation